However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower
At Pure Med Spa , we offer a modern, straightforward approach: a medically supervised, affordable, results-driven weight loss program delivered 100% virtually
Any use should be conducted under the supervision of a qualified healthcare professional
In fact, the 2026 NFP U.S
Who's Eligible for the GLP-1 Bridge Program
Clinical trial data for GLP-1 medicines, including Ozempic, Mounjaro, Wegovy/Wegovy HD, Zepbound, and Foundayo, were reviewed to compare reported weight-loss results, FDA-approved uses, and study limitations